Pneumococcal conjugate vaccination for adults: why itʼs important for children

This publication has 30 references indexed in Scilit:

• The Health and Economic Benefits Associated With Pneumococcal Vaccination of Elderly Persons With Chronic Lung Disease
  Archives of internal medicine (1960), 1999
• Haemophilus influenzae type b meningitis in The Gambia after introduction of a conjugate vaccine
  The Lancet, 1999
• The burden of pneumococcal disease among adults in developed and developing countries: what is and is not known
  Vaccine, 1999
• Correlation of Opsonophagocytosis and Passive Protection Assays Using Human Anticapsular Antibodies in an Infant Mouse Model of Bacteremia forStreptococcus pneumoniae
  The Journal of Infectious Diseases, 1999
• The clinical effectiveness of pneumococcal vaccination:
  Vaccine, 1999
• IgG subclass distribution of antibodies after vaccination of adults with pneumococcal conjugate vaccines
  Vaccine, 1999
• IgG Responses to Protein‐Conjugated Pneumococcal Capsular Polysaccharides in Persons Who Are Genetically Incapable of Responding to Unconjugated Polysaccharides
  Clinical Infectious Diseases, 1998
• Combined schedule of 7-valent pneumococcal conjugate vaccine followed by 23-valent pneumococcal vaccine in children and young adults with sickle cell disease
  The Journal of Pediatrics, 1998
• Evaluating New Vaccines for Developing Countries
  JAMA, 1996
• Pneumococcal Polysaccharide Vaccine Efficacy
  JAMA, 1993